GlassScriptPhysician profile
Rami Al-Aref
NPI 1033571229
$5,902.38
in general payments reported to CMS, 2019-2025
8 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.21 · 2023: $2,923 · 2024: $1,384 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,843 · Food and Beverage: $1,501 · Education: $1,500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,842.65 |
| Food and Beverage | $1,500.78 |
| Education | $1,500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,904.90 | 2023-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,423.02 | 2023 | Advantagerib, Ribfix Blu Advantage |
| Davol INC. | $298.79 | 2023-2024 | Phasix Mesh |
| Kerecis Limited | $153.53 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Acera Surgical, INC. | $58.05 | 2023 | Restrata Wound Matrix |
| Abiomed | $26.35 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.86 | 2022 | |
| Teleflex LLC | $13.88 | 2024 | Quikclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Al-Aref listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.